Curia is part of a larger corporation, Innoplexus, an AI platform focussing on drug discovery and development. The concept of Curia began as a mission to support cancer patients who were asking for help to find the right information about their options during their journey. With that as our mandate, we used Innoplexus technology to create the Curia app and bring current, accurate and relevant information to cancer patients.
Our app launched in June 2020 in Germany. We will be launching soon in other European countries, the Americas and Asia.